Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond P Goodrich

Transfusion

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Transfusion|March 13, 2018
Ignorance is not blissRaymond P Goodrich
Transfusion|November 13, 2012
In reply to: "Is the SCID mouse model applicable to human acute lung injury?"Raymond P Goodrich
Transfusion|April 9, 2010
Defining "adequate" pathogen reduction performance for transfused blood componentsRaymond P Goodrich, Brian Custer, Shawn Keil, et al.
Transfusion|August 22, 2009
Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentratesDaniel R Ambruso, Gail Thurman, Susanne Marschner, et al.
Transfusion|March 27, 2009
A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concernsRaymond P Goodrich, Denise Gilmour, Nick Hovenga, et al.
Transfusion|March 26, 2013
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatmentPeter Schubert, Danielle Coupland, Brankica Culibrk, et al.
Transfusion|November 8, 2005
Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storageJunzhi Li, Laura Goodrich, Eric Hansen, et al.
Transfusion|June 10, 2010
White blood cell inactivation after treatment with riboflavin and ultraviolet lightSusanne Marschner, Loren D Fast, William M Baldwin, et al.
Transfusion|August 18, 2009
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatmentRachael P Jackman, John W Heitman, Susanne Marschner, et al.
Transfusion|June 7, 2005
Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technologyJunzhi Li, Owen Lockerbie, Dirk de Korte, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Transfusion|March 13, 2018
Ignorance is not blissRaymond P Goodrich
Transfusion|November 13, 2012
In reply to: "Is the SCID mouse model applicable to human acute lung injury?"Raymond P Goodrich
Transfusion|April 9, 2010
Defining "adequate" pathogen reduction performance for transfused blood componentsRaymond P Goodrich, Brian Custer, Shawn Keil, et al.
Transfusion|August 22, 2009
Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentratesDaniel R Ambruso, Gail Thurman, Susanne Marschner, et al.
Transfusion|March 27, 2009
A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concernsRaymond P Goodrich, Denise Gilmour, Nick Hovenga, et al.
Transfusion|March 26, 2013
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatmentPeter Schubert, Danielle Coupland, Brankica Culibrk, et al.
Transfusion|November 8, 2005
Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storageJunzhi Li, Laura Goodrich, Eric Hansen, et al.
Transfusion|June 10, 2010
White blood cell inactivation after treatment with riboflavin and ultraviolet lightSusanne Marschner, Loren D Fast, William M Baldwin, et al.
Transfusion|August 18, 2009
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatmentRachael P Jackman, John W Heitman, Susanne Marschner, et al.
Transfusion|June 7, 2005
Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technologyJunzhi Li, Owen Lockerbie, Dirk de Korte, et al.
Pageof 4